Remdesivir therapy for severe pediatric COVID-19 in Singapore: a single-center retrospective observational cohort study

Remdesivir therapy for severe pediatric COVID-19 in Singapore: a single-center retrospective observational cohort study

There is a paucity of information on remdesivir (RDV) use in severe pediatric coronavirus disease 2019 (COVID-19). We aimed to explore the effectiveness of RDV as the cumulative proportion of pediatric COVID-19 patients deescalated from Day 5 of high dependency or intensive care unit (HD/ICU).

Bibliographic Details
Main Authors: Seah, Valerie Xue Fen, Ong, Rina Yue Ling, Kam, Kai-Qian, Thoon, Koh Cheng, Tan, Natalie Woon Hui, Li, Jiahui, Nadua, Karen Donceras, Chong, Chia Yin, Yung, Chee Fu
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Journal Article
Language:English
Published: 2024
Subjects:
Medicine, Health and Life Sciences
Children
Pediatric
Online Access:https://hdl.handle.net/10356/173749

Internet

https://hdl.handle.net/10356/173749

Similar Items